COVID-19 mRNA vaccines can trigger the immune system to recognize and kill cancer, research finds
PositiveScience

Recent research has revealed that mRNA-based COVID-19 vaccines may offer a new avenue for cancer treatment, particularly for patients whose tumors are resistant to conventional immunotherapy. This finding is significant as it opens up possibilities for enhancing the immune system's ability to recognize and eliminate cancer cells, potentially improving outcomes for many patients.
— Curated by the World Pulse Now AI Editorial System










